Gastrointestinal Cancer News

CHICAGO — Race, ethnicity and rurality have a significant impact on colorectal cancer screening disparities, highlighting the need for interventions to overcome these barriers, according to data presented at Digestive Disease Week.

CHICAGO — A multicomponent strategy, which included patient and provider outreach, increased colorectal cancer screening in individuals overdue for colonoscopy who have a family history of CRC, according to data at Digestive Disease Week.

CHICAGO — Among those who survived early-onset colorectal cancer, approximately 16% developed a second cancer, with higher risk reported among men, according to a population-based study presented at Digestive Disease Week.

In this video, James Cleary, MD, PhD, a medical oncologist at Dana-Farber Cancer Institute, discussed results from the phase 3 IMbrave050 trial, presented at American Association for Cancer Research Annual Meeting.

Obesity-related cancer mortality rates tended to be higher in counties with limited access to grocery stores or greater access to fast food, according to data published in JAMA Oncology.

Low-dose olanzapine significantly improved appetite and weight gain among patients with newly diagnosed cancer undergoing chemotherapy, according to study results published in Journal of Clinical Oncology.

Guidelines that recommend stool-based screening for colorectal cancer should emphasize strict adherence and offer screening colonoscopy as an alternative option, researchers reported in Gastroenterology.

Asthma appeared associated with a 1.36-fold increased risk for developing cancer, according to research conducted at University of Florida.

For patients who undergo surgery for stage III colon cancer, physical activity appears to prevent — rather than merely delay — recurrence of the disease, according to a study published in British Journal of Sports Medicine.

Cancers with high vs. low tumor mutational burden appeared significantly associated with improved clinical outcomes among patients treated with immune checkpoint inhibitors, according to data published in JAMA Network Open.